ANTISURASE B-96 II (TMB) (Anti-HBs)
High-accuracy quantitative ELISA for measuring Anti-HBs antibodies in serum/plasma. 100% sensitivity, 99.52% specificity. 50 µL sample, 90-minute assay. TFDA & CE approved.
PRODUCT DESCRIPTION
This in vitro diagnostic quantitative ELISA reagent is designed for measuring antibodies against Hepatitis B surface antigen (Anti-HBs) in human serum or plasma. It operates via the sandwich ELISA principle, using 50 µL of sample with an incubation time of 90 minutes and readout at 450 nm. Clinical evaluation in 838 hospitalized patients revealed 100% sensitivity and 99.52% specificity, with both intra-assay and inter-assay precision CV < 15%. Certified under TFDA and CE 0344. Ideal for monitoring immune status following vaccination and supporting diagnostic decisions.
PERFORMANCE
838 hospitalized patients were tested. The diagnostic sensitivity is 100%；The diagnostic specificity is 99.52%
The precision results of ANTISURASE B-96 II (TMB) indicated a high level of precision with CV (%) < 25% within runs, between runs, days, sites, operators, and lots.
SPECIFICATION
✱Notified body: 0344
| Number of wells | 96 |
| Principle | Sandwich |
| Assay format | Quantitative |
| Total incubation time | 90 minutes |
| Sample type | Serum / Plasma |
| Sample volume | 50 μL |
| Reading wavelength | 450nm |
| Storage | 2-8°C |
| Certification | TFDA / CE marked ✱ |
ORDERING INFORMATION
| Catalogue No. | Product |
|---|---|
| 4SBE6 | ANTISURASE B-96 TMB II (Anti-HBs Quantitative) – 96T |